Parkman Healthcare Partners’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-38,014
Closed -$8.56M 95
2024
Q2
$8.56M Sell
38,014
-59,891
-61% -$13.9M 1.15% 35
2024
Q1
$23.8M Sell
97,905
-4,986
-5% -$1.15M 2.92% 8
2023
Q4
$21.1M Buy
102,891
+6,046
+6% +$1.18M 2.98% 6
2023
Q3
$17.4M Buy
96,845
+10,595
+12% +$1.96M 3.19% 6
2023
Q2
$16.6M Buy
+86,250
New +$14.9M 2.88% 8

Other funds holding COR

Parkman Healthcare Partners's COR Position: Q3 2024 in Review

Parkman Healthcare Partners sold out of Cencora (COR) in Q3 2024, closing a stake of 38,014 shares — an estimated $8.56M sold.

Parkman Healthcare Partners first reported a position in COR in Q2 2023 and held it in 5 quarters. The position peaked at $23.8M in Q1 2024. 1,161 funds tracked by Wall St. Rank hold COR as of Q3 2024.

  • Parkman Healthcare Partners reported no remaining Cencora position as of Q3 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 38,014 Cencora shares in Q3 2024, an estimated $8.56M.
  • Parkman Healthcare Partners first reported a position in Cencora in Q2 2023 and held it in 5 quarters.
  • Parkman Healthcare Partners's Cencora position peaked at $23.8M in Q1 2024.
  • 1,161 funds tracked by Wall St. Rank held Cencora as of Q3 2024.

Based on Parkman Healthcare Partners's 13F filing for Q3 2024, filed 14 Nov 2024.